Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 20/20 | 0.79 |
| ▸ | CTSV | O60911 | 2/20 | 0.79 |
| ▸ | CTSL | P07711 | 2/20 | 0.79 |
| ▸ | CTSS | P25774 | 2/20 | 0.79 |
| ▸ | CTSB | P07858 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6197793 | 0.88 | CTSK (1.00) | CTSKCTSVCTSLCTSSCTSB | |
| SCHEMBL14104864 | 0.85 | CTSK (0.57) | CTSKCTSVCTSLCTSSCTSB | |
| SCHEMBL8354729 | 0.80 | CTSK (0.84) | CTSKCTSVCTSLCTSSCTSB | |
| SCHEMBL4819332 | 0.79 | CTSK (0.59) | CTSKCTSVCTSLCTSSCTSB | |
| SCHEMBL4819313 | 0.79 | CTSK (0.59) | CTSKCTSVCTSLCTSSCTSB | |
| SCHEMBL8354386 | 0.73 | CTSK (1.00) | CTSKCTSVCTSLCTSSCTSB | |
| SCHEMBL8354383 | 0.73 | CTSK (1.00) | CTSKCTSVCTSLCTSSCTSB | |
| SCHEMBL4818447 | 0.72 | CTSK (0.79) | CTSKCTSVCTSLCTSSCTSB | |
| SCHEMBL4818454 | 0.72 | CTSK (0.79) | CTSKCTSVCTSLCTSSCTSB | |
| SCHEMBL4817812 | 0.72 | CTSK (0.71) | CTSKCTSVCTSLCTSSCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7402606-B2 | Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss | SMITHKLINE BEECHAM CORPORATION (US) | 2008-07-22 | — | — | US | disclosed |
| US-7402606-B2 | Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss | SMITHKLINE BEECHAM CORPORATION (US) | 2008-07-22 | — | — | US | disclosed |
| WO-2003086385-A1 | DERIVATIVES OF 1-(OXOAMINOACETYL) PENTYLCARBAMATE AS CATHEPSIN K INHIBITORS FOR THE TREATMENT OF BONE LOSS | SMITHKLINE BEECHAM CORPORATION (US) | 2003-10-23 | — | — | WO | disclosed |